{"id":"W2520082135","doi":"10.1186/s13195-016-0207-9","title":"Drug development in Alzheimer’s disease: the path to 2025","year":2016,"lang":"en","type":"review","venue":"Alzheimer s Research & Therapy","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":455,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Biogen; Danone; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Sanofi; National Institute on Aging; Eli Lilly and Company; Alzheimer's Drug Discovery Foundation","keywords":"Drug development; Disease; Clinical trial; Standardization; Medicine; Risk analysis (engineering); Data sharing; Set (abstract data type); Computer science; Psychology; Drug; Alternative medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04164019,0.00137581,0.001801741,0.001945168,0.002662205,0.01174519,0.0025826,0.01307236,0.02643883],"category_scores_gemma":[0.04103045,0.0006352996,0.001620334,0.001847,0.006729065,0.02075845,0.007629455,0.01650137,0.008590748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007416854,"about_ca_system_score_gemma":0.0274642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003022925,"about_ca_topic_score_gemma":0.004978437,"domain_scores_codex":[0.977825,0.009488373,0.001764745,0.001517736,0.006972259,0.00243191],"domain_scores_gemma":[0.9517359,0.02221027,0.002542211,0.001892503,0.01010467,0.01151446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003893817,0.0003138611,0.0012219,0.002334733,0.0000963224,0.0003409144,0.0005539486,0.0008289257,0.001083806,0.1702975,0.4726076,0.3499312],"study_design_scores_gemma":[0.00007912648,0.0004658202,0.001197584,0.002463363,0.00004826518,0.0003694195,0.0007175396,0.0006039183,0.0003850716,0.09708545,0.8965146,0.00006990149],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001748139,0.1527954,0.005528437,0.8018524,0.01531836,0.00007839739,0.0003893876,0.0003258888,0.02196354],"genre_scores_gemma":[0.05549598,0.3018537,0.03944546,0.5576285,0.0243108,0.000389437,0.001318744,0.0004768561,0.01908046],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.04164019,"threshold_uncertainty_score":0.220217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2568617205341319,"score_gpt":0.4792626595672915,"score_spread":0.2224009390331596,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}